Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Milestone Scientific (MLSS) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Milestone Scientific (MLSS) over the last 16 years, with Q3 2025 value amounting to 48.07%.

  • Milestone Scientific's EBITDA Margin rose 103800.0% to 48.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 75.25%, marking a year-over-year increase of 5500.0%. This contributed to the annual value of 78.8% for FY2024, which is 64800.0% down from last year.
  • As of Q3 2025, Milestone Scientific's EBITDA Margin stood at 48.07%, which was up 103800.0% from 64.56% recorded in Q2 2025.
  • Milestone Scientific's 5-year EBITDA Margin high stood at 33.66% for Q1 2021, and its period low was 175.01% during Q2 2022.
  • In the last 5 years, Milestone Scientific's EBITDA Margin had a median value of 78.27% in 2023 and averaged 81.33%.
  • Per our database at Business Quant, Milestone Scientific's EBITDA Margin surged by 17738800bps in 2021 and then crashed by -565900bps in 2022.
  • Milestone Scientific's EBITDA Margin (Quarter) stood at 54.89% in 2021, then tumbled by -64bps to 89.9% in 2022, then rose by 3bps to 87.57% in 2023, then dropped by -18bps to 103.57% in 2024, then soared by 54bps to 48.07% in 2025.
  • Its EBITDA Margin was 48.07% in Q3 2025, compared to 64.56% in Q2 2025 and 89.59% in Q1 2025.